Insider Transactions in Q1 2024 at Longeveron Inc. (LGVN)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 12
2024
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,866
-26.8%
|
$0
$0.54 P/Share
|
Mar 12
2024
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,200
+39.54%
|
-
|
Jan 10
2024
|
Cathy Ross |
BUY
Open market or private purchase
|
Direct |
5,000
+33.33%
|
$5,000
$1.31 P/Share
|
Jan 02
2024
|
Nataliya Agafonova Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,074
-12.88%
|
$3,074
$1.32 P/Share
|
Jan 02
2024
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
992
-0.69%
|
$992
$1.32 P/Share
|
Jan 02
2024
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,123
-10.77%
|
$5,123
$1.32 P/Share
|
Jan 02
2024
|
Lisa Locklear Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,098
-10.01%
|
$4,098
$1.32 P/Share
|